Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Replacement in Adolescent Females at Risk for PCOS
NCT04355572Recruiting
- Sponsor
- Yale University
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in polycystic ovary syndrome (PCOS) and Vitamin D deficiency (VDD) comparing Vitamin D Supplement with Placebo (2 arms). Primary endpoints: Change in oligomenorrhea at 6 months and Changes Vitamin D (25-hydroxyvitamin D) level at 6 months. Started Sep 2026; status: recruiting.
02
Drugs
vitamin d
03
Conditions
polycystic ovary syndrome (PCOS)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT04355572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355572.